Guardion Health Sciences Inc   (GHSI)
Other Ticker:  
Price: $9.2500 $0.15 1.593%
Day's High: $9.292 Week Perf: 17.09 %
Day's Low: $ 9.17 30 Day Perf: 13.5 %
Volume (M): 3 52 Wk High: $ 10.75
Volume (M$): $ 29 52 Wk Avg: $7.21
Open: $9.17 52 Wk Low: $5.01

 Market Capitalization (Millions $) 12
 Shares Outstanding (Millions) 1
 Employees -
 Revenues (TTM) (Millions $) 11
 Net Income (TTM) (Millions $) -5
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) 0

Guardion Health Sciences Inc
Guardion Health Sciences Inc is a healthcare company that specializes in developing and commercializing medical nutrition and diagnostics solutions. The company focuses on improving overall health and wellness, with a particular emphasis on eye health. Guardion Health Sciences offers various products and services, including nutraceuticals and medical foods to support healthy vision, as well as genetic testing and diagnostic services to identify and manage various health conditions. The company aims to provide personalized healthcare solutions to individuals and healthcare professionals globally.

   Company Address: 2925 Richmond Avenue Houston 77098 TX
   Company Phone Number: 873-5141   Stock Exchange / Ticker: NASDAQ GHSI


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Guardion Health Sciences Inc

Guardion Health Sciences Inc. Shines with Strong Financial Performance in Recent Fiscal Period

The stock market has been buzzing with excitement as Guardion Health Sciences Inc (GHSI) has reported some impressive numbers for the October to December 31, 2023 fiscal span. Investors were pleased to see that GHSI turned a profit of $0.33 per share, a significant improvement from the loss of $0.16 per share in the same period a year earlier. This represents a 14.85% growth in earnings per share from the previous reporting season.
Furthermore, GHSI saw a 10.505% increase in revenue, reaching $4.35 million compared to $3.94 million in the corresponding reporting season a year prior. Sequentially, revenue surged by an impressive 76.799% from $2.46 million. This growth in revenue and profitability is a positive sign for the company as it continues to expand and enhance its market position.

Guardion Health Sciences Inc

Guardion Health Sciences Inc witnesses impressive double-digit growth during July-September 2023 period

uardion Health Sciences Inc. (GHSI) recently reported positive third-quarter earnings for the interval July to September 2023. Despite this encouraging news, there are several reasons to remain bearish on the stock. This article will delve into the potential challenges facing GHSI in the major pharmaceutical preparations sector and analyze its financial performance and market trends.
Revenue Growth and Earnings Improvement:
While GHSI showcased an admirable revenue growth of 17.818% to $2.46 million in the corresponding reporting season a year ago, it is essential to assess this growth in the context of the industry's overall performance. The observed revenue growth may not be sustainable, as many entities within the sector are experiencing declining top-line figures and dwindling transactions.

Guardion Health Sciences Inc

Guardion Health Sciences Inc Reports Slight Revenue Downturn during Q2 2023 Earnings Season

Guardion Health Sciences Inc Reports Decreased Revenue and Increased Shortfall
Guardion Health Sciences Inc, a major player in the pharmaceutical preparations industry, has recently released its latest financial reports for the most recent fiscal period. The company's performance has witnessed a downward spiral during this period, as it reported substantial declines in revenue and a significant increase in the shortfall per share compared to the previous year.
In terms of earnings per share (EPS), Guardion Health Sciences Inc's shortfall per share for the most recent fiscal period stood at $-0.93, a notable increase compared to $-0.03 reported a year ago. Moreover, the company experienced a decline in EPS from $0.42 per share in the preceding quarter. These figures indicate a concerning trend for the company's profitability.


Guardion Health Sciences Inc's Segments
• View Complete Report
  Company Estimates  
  Revenue Outlook
Guardion Health Sciences Inc does not provide revenue guidance.

Earnings Outlook
Guardion Health Sciences Inc does not provide earnings estimates.

Geographic Revenue Dispersion


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com